Results 231 to 240 of about 22,763,092 (350)

Interstitial Cystitis/Bladder Pain Syndrome Patient Phenotyping

open access: yesNeurourology and Urodynamics, Volume 45, Issue 1, Page 19-25, January 2026.
ABSTRACT Aims In April of 2025, the Wake Forest Institute for Regenerative Medicine hosted a Global Consensus meeting on IC/BPS in Winston‐Salem, NC. The goal of this meeting was to establish global consensus regarding diagnostic criteria, phenotyping, treatment outcome assessment, and etiopathology in interstitial cystitis/bladder pain syndrome (IC ...
Dylan T. Wolff   +5 more
wiley   +1 more source

Tissue‐specific expression of murine Nkx3.1 in the male urogenital system

open access: yesDevelopmental Dynamics, 1997
P. Sciavolino   +5 more
semanticscholar   +1 more source

Role of Gynecologic Findings in Interstitial Cystitis/Bladder Pain Syndrome: A Consensus

open access: yesNeurourology and Urodynamics, Volume 45, Issue 1, Page 39-45, January 2026.
ABSTRACT Objective To evaluate the role of gynecologic findings in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by reviewing current international guidelines and identifying relevant gynecologic co‐morbidities. Methods This consensus statement was developed through a systematic four‐phase process: (1) comprehensive literature review across ...
Marie E. Sullivan   +5 more
wiley   +1 more source

Histological Analysis of the Prostate During the Human Fetal Period (12 to 22 Weeks Post-Conception). [PDF]

open access: yesInt Braz J Urol
Alves EF   +4 more
europepmc   +1 more source

Efficacy and Safety of Sacral Neuromodulation on Patients With Multiple Sclerosis and Lower Urinary Tract Dysfunction: A Systematic Review and Meta‐Analysis

open access: yesNeurourology and Urodynamics, Volume 45, Issue 1, Page 187-199, January 2026.
ABSTRACT Aim Treating multiple sclerosis (MS)‐related adult neurogenic lower urinary tract dysfunction (ANLUTD) is challenging because conservative treatments are often ineffective. Sacral neuromodulation (SNM) is a promising minimally invasive treatment of ANLUTD. This review assesses the efficacy and safety of SNM for MS‐related ANLUTD.
Carlos Ferreira   +8 more
wiley   +1 more source

Correlates of Positive Response to Therapeutic Hydrodistension in Interstitial Cystitis/Bladder Pain Syndrome

open access: yesNeurourology and Urodynamics, Volume 45, Issue 1, Page 169-176, January 2026.
ABSTRACT Aims The objective of this study was to assess the duration and clinical correlates of positive response in interstitial cystitis/bladder pain syndrome patients undergoing therapeutic bladder hydrodistension (HOD) or HOD with electrofulguration (for those with Hunner lesions).
Dylan T. Wolff   +5 more
wiley   +1 more source

The Incremental Yield of CMA Over Karyotype in Fetal Growth Restriction—A Systematic Review and Meta‐Analysis

open access: yesPrenatal Diagnosis, Volume 46, Issue 1, Page 56-74, January 2026.
ABSTRACT The main objective of our study was to conduct a systematic literature review and a meta‐analysis to evaluate the incremental yield of chromosomal microarray analysis compared with karyotyping in cases of fetal growth restriction. Our review was designed according to the PRISMA guidelines.
Ioakeim Sapantzoglou   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy